158 related articles for article (PubMed ID: 16307879)
1. Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRgamma.
Chao EY; Collins JL; Gaillard S; Miller AB; Wang L; Orband-Miller LA; Nolte RT; McDonnell DP; Willson TM; Zuercher WJ
Bioorg Med Chem Lett; 2006 Feb; 16(4):821-4. PubMed ID: 16307879
[TBL] [Abstract][Full Text] [Related]
2. Requirements for transcriptional regulation by the orphan nuclear receptor ERRgamma.
Huppunen J; Wohlfahrt G; Aarnisalo P
Mol Cell Endocrinol; 2004 Apr; 219(1-2):151-60. PubMed ID: 15149736
[TBL] [Abstract][Full Text] [Related]
3. Development of a coactivator displacement assay for the orphan receptor estrogen-related receptor-gamma using time-resolved fluorescence resonance energy transfer.
Gowda K; Marks BD; Zielinski TK; Ozers MS
Anal Biochem; 2006 Oct; 357(1):105-15. PubMed ID: 16889744
[TBL] [Abstract][Full Text] [Related]
4. Efficient discovery of selective small molecule agonists of estrogen-related receptor gamma using combinatorial approach.
Kim Y; Koh M; Kim DK; Choi HS; Park SB
J Comb Chem; 2009; 11(5):928-37. PubMed ID: 19746993
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity.
Greschik H; Flaig R; Renaud JP; Moras D
J Biol Chem; 2004 Aug; 279(32):33639-46. PubMed ID: 15161930
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor ligands. II. Discovery of benzoxathiins as potent, selective estrogen receptor alpha modulators.
Kim S; Wu JY; Birzin ET; Frisch K; Chan W; Pai LY; Yang YT; Mosley RT; Fitzgerald PM; Sharma N; Dahllund J; Thorsell AG; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
J Med Chem; 2004 Apr; 47(9):2171-5. PubMed ID: 15084115
[TBL] [Abstract][Full Text] [Related]
7. The discovery of tetrahydrofluorenones as a new class of estrogen receptor beta-subtype selective ligands.
Wilkening RR; Ratcliffe RW; Tynebor EC; Wildonger KJ; Fried AK; Hammond ML; Mosley RT; Fitzgerald PM; Sharma N; McKeever BM; Nilsson S; Carlquist M; Thorsell A; Locco L; Katz R; Frisch K; Birzin ET; Wilkinson HA; Mitra S; Cai S; Hayes EC; Schaeffer JM; Rohrer SP
Bioorg Med Chem Lett; 2006 Jul; 16(13):3489-94. PubMed ID: 16632357
[TBL] [Abstract][Full Text] [Related]
8. A structure-guided approach to an orthogonal estrogen-receptor-based gene switch activated by ligands suitable for in vivo studies.
Kinzel O; Fattori D; Muraglia E; Gallinari P; Nardi MC; Paolini C; Roscilli G; Toniatti C; Gonzalez Paz O; Laufer R; Lahm A; Tramontano A; Cortese R; De Francesco R; Ciliberto G; Koch U
J Med Chem; 2006 Sep; 49(18):5404-7. PubMed ID: 16942012
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones.
McDevitt RE; Malamas MS; Manas ES; Unwalla RJ; Xu ZB; Miller CP; Harris HA
Bioorg Med Chem Lett; 2005 Jun; 15(12):3137-42. PubMed ID: 15876535
[TBL] [Abstract][Full Text] [Related]
10. De novo design, synthesis, and evaluation of novel nonsteroidal phenanthrene ligands for the estrogen receptor.
Schmidt JM; Mercure J; Tremblay GB; Pagé M; Kalbakji A; Feher M; Dunn-Dufault R; Peter MG; Redden PR
J Med Chem; 2003 Apr; 46(8):1408-18. PubMed ID: 12672240
[TBL] [Abstract][Full Text] [Related]
11. X-ray crystal structures of the estrogen-related receptor-gamma ligand binding domain in three functional states reveal the molecular basis of small molecule regulation.
Wang L; Zuercher WJ; Consler TG; Lambert MH; Miller AB; Orband-Miller LA; McKee DD; Willson TM; Nolte RT
J Biol Chem; 2006 Dec; 281(49):37773-81. PubMed ID: 16990259
[TBL] [Abstract][Full Text] [Related]
12. Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor gamma (ERRgamma) with high constitutive activity.
Takayanagi S; Tokunaga T; Liu X; Okada H; Matsushima A; Shimohigashi Y
Toxicol Lett; 2006 Dec; 167(2):95-105. PubMed ID: 17049190
[TBL] [Abstract][Full Text] [Related]
13. Structure-guided optimization of estrogen receptor binding affinity and antagonist potency of pyrazolopyrimidines with basic side chains.
Zhou HB; Sheng S; Compton DR; Kim Y; Joachimiak A; Sharma S; Carlson KE; Katzenellenbogen BS; Nettles KW; Greene GL; Katzenellenbogen JA
J Med Chem; 2007 Jan; 50(2):399-403. PubMed ID: 17228884
[TBL] [Abstract][Full Text] [Related]
14. 4-Hydroxytamoxifen is an isoform-specific inhibitor of orphan estrogen-receptor-related (ERR) nuclear receptors beta and gamma.
Tremblay GB; Bergeron D; Giguere V
Endocrinology; 2001 Oct; 142(10):4572-5. PubMed ID: 11564725
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of novel 4-hydroxytamoxifen analogs as estrogen-related receptor gamma inverse agonists.
Kim J; Chin J; Im CY; Yoo EK; Woo S; Hwang HJ; Cho JH; Seo KA; Song J; Hwang H; Kim KH; Kim ND; Yoon SK; Jeon JH; Yoon SY; Jeon YH; Choi HS; Lee IK; Kim SH; Cho SJ
Eur J Med Chem; 2016 Sep; 120():338-52. PubMed ID: 27236015
[TBL] [Abstract][Full Text] [Related]
16. Promising core structure for nuclear receptor ligands: design and synthesis of novel estrogen receptor ligands based on diphenylamine skeleton.
Ohta K; Chiba Y; Ogawa T; Endo Y
Bioorg Med Chem Lett; 2008 Sep; 18(18):5050-3. PubMed ID: 18760603
[TBL] [Abstract][Full Text] [Related]
17. Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators.
Jin KS; Park JK; Yoon J; Rho Y; Kim JH; Kim EE; Ree M
J Phys Chem B; 2008 Aug; 112(32):9603-12. PubMed ID: 18646811
[TBL] [Abstract][Full Text] [Related]
18. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.
Shiau AK; Barstad D; Loria PM; Cheng L; Kushner PJ; Agard DA; Greene GL
Cell; 1998 Dec; 95(7):927-37. PubMed ID: 9875847
[TBL] [Abstract][Full Text] [Related]
19. Distinction of the binding modes for human nuclear receptor ERRgamma between bisphenol A and 4-hydroxytamoxifen.
Liu X; Matsushima A; Okada H; Shimohigashi Y
J Biochem; 2010 Aug; 148(2):247-54. PubMed ID: 20542892
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.
Ghosh AK; Kumaragurubaran N; Hong L; Kulkarni SS; Xu X; Chang W; Weerasena V; Turner R; Koelsch G; Bilcer G; Tang J
J Med Chem; 2007 May; 50(10):2399-407. PubMed ID: 17432843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
